Tamarixetin-3-O-rutinosideCAS# 20550-05-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 20550-05-4 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C28H32O16 | M.Wt | 624.55 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Tamarixetin-3-O-rutinoside Dilution Calculator
Tamarixetin-3-O-rutinoside Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6012 mL | 8.0058 mL | 16.0115 mL | 32.0231 mL | 40.0288 mL |
| 5 mM | 0.3202 mL | 1.6012 mL | 3.2023 mL | 6.4046 mL | 8.0058 mL |
| 10 mM | 0.1601 mL | 0.8006 mL | 1.6012 mL | 3.2023 mL | 4.0029 mL |
| 50 mM | 0.032 mL | 0.1601 mL | 0.3202 mL | 0.6405 mL | 0.8006 mL |
| 100 mM | 0.016 mL | 0.0801 mL | 0.1601 mL | 0.3202 mL | 0.4003 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- trans-p-Coumaric acid 4-O-β-D-glucopyranoside
Catalog No.:BCX1068
CAS No.:117405-49-9
- Cochinchinenin A
Catalog No.:BCX1067
CAS No.:1057666-04-2
- Resveratrol 12-C-β-glucopyranoside
Catalog No.:BCX1066
CAS No.:163527-00-2
- Crocetine dimethyl ester
Catalog No.:BCX1065
CAS No.:5892-54-6
- Podecdysone B
Catalog No.:BCX1064
CAS No.:22612-27-7
- Notoginsenoside ST4
Catalog No.:BCX1063
CAS No.:155683-02-6
- (+)-Epitaxifolin
Catalog No.:BCX1062
CAS No.:153666-25-2
- Paeoniflorin sulfite
Catalog No.:BCX1061
CAS No.:1146967-98-7
- 2'-Fucosyllactose
Catalog No.:BCX1060
CAS No.:41263-94-9
- Myriacetin
Catalog No.:BCX1059
CAS No.:203734-35-4
- Phloretin 2'-xyloglucoside
Catalog No.:BCX1058
CAS No.:145758-09-4
- 5-Hydroxyferulic acid
Catalog No.:BCX1057
CAS No.:1782-55-4
- 2-O-α-D-Glucopyranosyl-L-ascorbic acid
Catalog No.:BCX1070
CAS No.:129499-78-1
- Stachyanthuside A
Catalog No.:BCX1071
CAS No.:864779-30-6
- Prunetinoside
Catalog No.:BCX1072
CAS No.:89595-66-4
- Momilacton B
Catalog No.:BCX1073
CAS No.:51415-08-8
- Momilacton A
Catalog No.:BCX1074
CAS No.:51415-07-7
- γ-Tocopherol
Catalog No.:BCX1075
CAS No.:54-28-4
- Pseudoginsenoside Rh1
Catalog No.:BCX1076
CAS No.:97744-96-2
- Avenanthramide C
Catalog No.:BCX1077
CAS No.:116764-15-9
- 6-Methoxyldihydrochelerythrine chloride
Catalog No.:BCX1078
CAS No.:1071676-04-4
- 4-Deoxy-4α-phorbol
Catalog No.:BCX1079
CAS No.:37415-57-9
- Rhamnetin 3-O-rutinoside
Catalog No.:BCX1080
CAS No.:34202-83-0
- Pseudostellarin B
Catalog No.:BCX1081
CAS No.:156430-21-6
Transgenic tobacco plant overexpressing ginkgo dihydroflavonol 4-reductase gene GbDFR6 exhibits multiple developmental defects.[Pubmed:36589135]
Front Plant Sci. 2022 Dec 14;13:1066736.
Dihydroflavonol Q 4-reductase (DFR), a key enzyme in the flavonoid biosynthetic pathway in plants, significantly influences plant survival. However, the roles of DFR in the regulation of plant development are largely unknown. In the present study, phenotypes of transgenic tobacco plants overexpressing the Ginkgo biloba DFR gene, GbDFR6, were investigated. Transgenic tobacco seedlings exhibited relatively low fresh weights, long primary roots, decreased lateral root numbers, and impaired root gravitropic responses when compared to wild-type tobacco plants. Adult transgenic tobacco plants exhibited a considerably high percentage of wrinkled leaves when compared to the wild-type tobacco plants. In addition to the auxin-related phenotypic changes, transgenic tobacco plants exhibited delayed flowering phenotypes under short-day conditions. Gene expression analysis revealed that the delayed flowering in transgenic tobacco plants was caused by the low expression levels of NtFT4. Finally, variations in anthocyanin and flavonoid contents in transgenic tobacco plants were evaluated. The results revealed that the levels of most anthocyanins identified in transgenic tobacco leaves increased. Specifically, cyanidin-3,5-O-diglucoside content increased by 9.8-fold in transgenic tobacco plants when compared to the wild-type tobacco plants. Pelargonidin-3-O-(coumaryl)-glucoside was only detected in transgenic tobacco plants. Regarding flavonoid compounds, one flavonoid compound (epicatechin gallate) was upregulated, whereas seven flavonoid compounds (Tamarixetin-3-O-rutinoside; Sexangularetin-3-O-glucoside-7-O-rhamnoside; Kaempferol-3-O-neohesperidoside; Engeletin; 2'-Hydoxy,5-methoxyGenistein-O-rhamnosyl-glucoside; Diosmetin; Hispidulin) were downregulated in both transgenic tobacco leaves and roots. The results indicate novel and multiple roles of GbDFR6 in ginkgo and provide a valuable method to produce a late flowering tobacco variety in tobacco industry.
